Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01280604 · ClinicalTrials.gov registry record · NA
Effect of Fenofibrate Conversion on Triglyceride Levels in Patients on Statin Therapy
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT01280604 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 66 participants.
The verdict
NCT01280604, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The primary objective of this randomized trial is to measure the impact of converting patients on statin therapy from fenofibrate 160mg to 54mg per day compared to patients who continue fenofibrate 160mg per day for triglycerides.
Interventions
- DRUG Fenofibrate 54mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01280604
The ClinicalTrials.gov registry entry for NCT01280604 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fenofibrate 54mg is the first listed.
NCT01280604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01280604 about?
NCT01280604 is a clinical study titled "Effect of Fenofibrate Conversion on Triglyceride Levels in Patients on Statin Therapy". The primary objective of this randomized trial is to measure the impact of converting patients on statin therapy from fenofibrate 160mg to 54mg per day compared to patients who continue fenofibrate 160mg per day for triglycerides.
What is the current status of trial NCT01280604?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2010-10. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01280604?
The interventions under investigation include: Fenofibrate 54mg (DRUG).
Who is sponsoring clinical trial NCT01280604?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.